The research described in this thesis is focused on translating and validating patient-reported outcome measures for Dutch patients with interstitial lung diseases and pulmonary hypertension (part 1), develop patient-recorded outcome measures (part 2), and interventions aimed at improving quality of life for patients (part 3).

, , , , , , , , , , , , , , , , , , , , , , ,
J.G.J.V. Aerts (Joachim) , M.S. Wijsenbeek-Lourens (Marlies) , K.A.T. Boomars (Karin)
Erasmus University Rotterdam
Unrestricted research grants for research described in this thesis are gratefully acknowledged and have been received from: Erasmus MC Thorax Foundation, ILD Care Foundation, Dutch sarcoidosis patient foundation (SBN), Pender foundation of the Dutch pulmonary fibrosis patient association, Actelion Pharmaceuticals Ltd, Boehringer Ingelheim, GSK- the Netherlands and Intermune/ Hoffman la Roche
Department of Pulmonology

Wapenaar - de Korver, M. (2019, October 29). Patient-Reported and Patient-Recorded Outcomes in Interstitial Lung Diseases and Pulmonary Hypertension. Retrieved from